Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. III. Study of the mechanismR Cibotti, E Churaqui, I Bolonakis-Tsilivakos, et al.Revue Neurologique|March 7, 2006
[Cryptococcal meningo-encephalitis in an apparently immunocompetent patient]K Bretaudeau, O Eloy, A Richer, et al.The Journal of Infectious Diseases|May 9, 2001
Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramersD Scott-Algara, F Buseyne, S Blanche, et al.Virus Research|June 1, 1992
Nucleocapsid specific T and B cell responses in humans after rabies vaccinationM Herzog, M Lafage, J A Montaño-Hirose, et al.Clinical and Experimental Immunology|August 1, 1991
T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccinationM Herzog, C Fritzell, M Lafage, et al.Clinical and Experimental Immunology|August 29, 2002
Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse modelM Alfonzo, D Blanc, C Troadec, et al.Nature|August 6, 1992
Evidence for a viral superantigen in humansM Lafon, M Lafage, A Martinez-Arends, et al.Lasers in Surgery and Medicine|December 29, 2000
Short-term bioeffects of an infrared pulsed laser device on burned rat skin monitored by transverse relaxation times (NMR)L A Santana-Blank, E Rodríguez-Santana, D Scott-Algara, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 8, 2014
Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analoguesO Godon, H Fontaine, S Kahi, et al.The Journal of General Virology|April 1, 1993
In vitro non-productive infection of purified natural killer cells by the BRU isolate of the human immunodeficiency virus type 1D Scott-Algara, F Vuillier, A Cayota, et al.Pageof 4